Search Results - Wallweiner, D.

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    158. Pathological Complete Response is not the Best Prognostic Factor in Patients with Breast Cancer Treated by Preoperative Chemotherapy

    158. Pathological Complete Response is not the Best Prognostic Factor in Patients with Breast Cancer Treated by Preoperative Chemotherapy by Honig, A., Solomayer, E.F., Sinn, H.P., Meyberg, G.C., Grischke, E.M., Bastert, G., Wallweiner, D.

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    The triplet gemcitabine (G), epirubicin (E) and docetaxel (Doc) is feasible, safe and highly active as primary systemic therapy (PST) of patients (pts) with multicentric phase I/II trial

    The triplet gemcitabine (G), epirubicin (E) and docetaxel (Doc) is feasible, safe and highly active as primary systemic therapy (PST) of patients (pts) with multicentric phase I/II... by Schneeweiss, A., Geberth, M., Krauss, K., Beldermann, F., Wagner, U., von Fournier, D., Hamerla, R., Wallweiner, D., Bastert, G., Huober, J.

    Published in Breast (Edinburgh)
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: